Skip to main content
Premium Trial:

Request an Annual Quote

Commonwealth Biotechnologies and Web Services Firm to Design Database Analysis Tools

NEW YORK, July 23 - Commonwealth Biotechnologies has signed a letter-of-intent to partner with web and application infrastructure services company bayMountain to develop and commercialize genomic database analysis tools, the companies said Monday.

The terms of the agreement were not disclosed. 

"This is an outstanding opportunity for us to partner with a company whose expertise is in hosting, managing, and analyzing very complex and data-intensive applications," Robert Harris, president of Commonwealth Biotechnologies, said in a statement. "By focusing on relatively small genomes, such as pathogenic bacteria, we see a rapid commercialization of new and powerful software. CBI's expertise is in doing the underlying science needed to create the data. BayMountain's expertise is in providing the skills and tools necessary to manage and mine that data."

"Genomics is a key area of growth for the DNA services at CBI," added Tom Reynolds, senior vice president at Commonwealth Biotechnologies. "CBI is in the midst of two government-funded genome projects and is bidding for several more. Having the ability to do the science and to manage the database which is created will make us all the more attractive in competing for these projects."

Both companies are based in Richmond, Virginia.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.